Ind-Swift Laboratories Share Price
₹104.37 -2.13 (-2%)
28 Dec, 2024 03:30
Start SIP in INDSWFTLAB
Start SIPPerformance
- Low
- ₹104
- High
- ₹106
- 52 Week Low
- ₹86
- 52 Week High
- ₹186
- Open Price₹0
- Previous Close₹107
- Volume34,952
Investment Returns
- Over 1 Month + 7.99%
- Over 3 Month -20.19%
- Over 6 Month -14.9%
- Over 1 Year + 6.55%
Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!
Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 2.4
- PEG Ratio
- 0
- Market Cap Cr
- 617
- P/B Ratio
- 0.7
- Average True Range
- 2.73
- EPS
- 17.29
- Dividend Yield
- 0
- MACD Signal
- -0.33
- RSI
- 44.26
- MFI
- 39.11
Ind-Swift Laboratories Financials
Ind-Swift Laboratories Technicals
EMA & SMA
Current Price
₹104.37
-2.13
(-2%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹107.44
- 50 Day
- ₹111.34
- 100 Day
- ₹117.07
- 200 Day
- ₹117.16
Resistance and Support
104.75
- R3 106.25
- R2 105.88
- R1 105.12
- S1 103.99
- S2 103.62
- S3 102.86
Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-06-27 | Preferential issue of shares | |
2024-05-13 | Audited Results | |
2024-02-12 | Quarterly Results |
Ind-Swift Laboratories F&O
About Ind-Swift Laboratories
- NSE Symbol
- INDSWFTLAB
- BSE Symbol
- 532305
- Chairman & Managing Director
- Mr. Navrattan Munjal
- ISIN
- INE915B01019
Similar Stocks to Ind-Swift Laboratories
Ind-Swift Laboratories FAQs
Ind-Swift Laboratories share price is ₹104 As on 28 December, 2024 | 03:16
The Market Cap of Ind-Swift Laboratories is ₹616.7 Cr As on 28 December, 2024 | 03:16
The P/E ratio of Ind-Swift Laboratories is 2.4 As on 28 December, 2024 | 03:16
The PB ratio of Ind-Swift Laboratories is 0.7 As on 28 December, 2024 | 03:16
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.